The cell counting market is expected to witness significant growth in the coming seven years owing to the extensive use of cell counting techniques by research institutes, hospitals, biotechnology and pharmaceuticals companies as an important tool in research, drug discovery and biopharmaceutical applications. Other important factors such as an increasing prevalence of cancer patients, and government funding for development and research are expected to further fuel demand in the cell counting market.
For More Information on “Cell Counting Market Research Reports” visit – http://www.grandviewresearch.com/industry-analysis/cell-counting-market
It is expected that cell counting instruments will witness a steady growth in demand throughout the forecast period owing to the growing demand for cell culturing and analysis applications which use cell counting as a core fundamental parameter. Owing to increasing contract research, organizations providing significant opportunities to provide high-content screening services, growth in medical spending, and growing healthcare industry the cell counting market is expected to witness a growth in demand. Furthermore, rising incidences of cancer and increasing incidences of chronic and infectious diseases are expected to fuel demand in the cell analysis and cell diagnosis application segment. The introduction of improved image analysis, enhanced informatics solutions, and improved accuracy of cell imaging systems are expected to reduce costs and time involved in the drug discovery process.
The geographical analysis for cell counting market divides it into North America, Europe, Asia-Pacific and Latin America and MEA. North America accounted for the largest share of revenue for 2014. Asia Pacific is expected to grow at significant rate in the next seven years. This expected growth can be attributed to the increasing incidences of cancer, infectious and chronic diseases, and enhancement of healthcare services. Various developments such as the German government, collaboration with Biomet network to fund the Max Planck Institute of Molecular Cell Biology and Genetics (Germany) for enhancing high content screening in Europe are also expected to fuel global demand. The global cell analysis market is highly competitive because of the presence of well established firms and efforts made by new entrants to occupy market share. The key participants in the market are Advanced Cell Technologies Inc., Athersys, Celgene Corporation, Cellular Dynamics International, Cytori Therapeutics Inc., Fibrocell Science, Gamida Cell Limited, Mesoblast Limited, Pluristem Therapeutics Inc., Stemcells, and Aastrom Biosciences Inc.
Request TOC of “Cell Counting Market Research Reports” visit – http://www.grandviewresearch.com/industry-analysis/cell-counting-market/request-toc
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
Toll Free: 1-888-202-9519
Website: Grand View Research
Blog Site: http://www.divog.org/